2.35% -2.91

Dopo l'orario di chiusura: 120.31 -0.63 -0.52%

Revvity Inc (RVTY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RVTY Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Revvity Inc (RVTY)

Revvity Inc Borsa (RVTY) Ultime notizie

Revvity stock heads into the open after a 2.5% Nasdaq drop - ad-hoc-news.de

Revvity, Inc. entered into a definitive agreement to acquire Human Cell Design SAS. - marketscreener.com

RVTY Assumes Rating by UBS -- Price Target Raised to $140 - GuruFocus

Revvity at Wells Fargo 21st annual healthcare conference: growth and margin focus - Investing.com India

Revvity Acquiring French Firm Human Cell Design - GenomeWeb

Revvity Bets on GLP-1 Boom With Human Cell Design Acquisition - Benzinga

UBS Downgrades Revvity to Neutral From Buy, Adjusts Price Target to $140 From $120 - marketscreener.com

Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery - biospace.com

Revvity, Inc. at Wells Fargo Healthcare Conference Transcript - GuruFocus

RVTY Looks 8.1% Overvalued on GF Value™ - GuruFocus

RVTY Looks 8.1% Overvalued on GF Value™ as Acquisition Adds Grow - GuruFocus

Revvity to Acquire Human Cell Design - marketscreener.com

Revvity to acquire Human Cell Design - TradingView

Revvity to acquire Human Cell Design for metabolic research tools - Investing.com

Revvity to acquire Human Cell Design for metabolic research tools By Investing.com - Investing.com Canada

A planned Revvity deal would add human pancreatic cells for diabetes research - Stock Titan

Revvity Inc. stock slips despite solid Q2 2026 growth and cautious analyst outlook - ad-hoc-news.de

Revvity stock heads into the open after a 2.1 percent drop - ad-hoc-news.de

Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

T. Rowe Price controls over 10M Revvity (NYSE: RVTY) shares, with one fund holding about half the stake - Stock Titan

Revvity Inc. stock holds above 130 dollars as analysts stick with Hold ratings - ad-hoc-news.de

Revvity, Inc. (RVTY) Stock Analysis: Navigating Potential in the Diagnostics Sector Amid Mixed Ratings - DirectorsTalk Interviews

KeyBanc Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $165 - Moomoo

Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich? - Yahoo Finance

KeyBanc Adjusts Price Target on Revvity to $165 From $125, Maintains Overweight Rating - marketscreener.com

Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.

Revvity Inc. stock holds near 52-week high as valuation debate intensifies - AD HOC NEWS

Baird Adjusts Price Target on Revvity to $144 From $131, Keeps Outperform Rating - marketscreener.com

Revvity (RVTY) Stock Looks Fair On Cash Flow Yet Pricey On Earnings - Yahoo Finance

Revvity Inc (RVTY) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Revvity (RVTY) Margins Story Faces A Valuation Test Following Its Zacks Upgrade - Yahoo Finance

What Makes Revvity (RVTY) a New Buy Stock - finance.yahoo.com

Revvity Faces Growth Challenges Amid Rising Competition, RBC Says - marketscreener.com

RBC Initiates Revvity at Sector Perform With $135 Price Target - marketscreener.com

RBC Capital initiates Revvity stock with Sector Perform rating By Investing.com - Investing.com Australia

RBC Capital initiates Revvity stock with Sector Perform rating - Investing.com

Revvity, Inc. (RVTY) Stock Analysis: Navigating a 6% Potential Downside with Strategic Insights - DirectorsTalk Interviews

Revvity (RVTY) Eases to $128.8: Key Support at $122.36 Holds in FocusImbalance Zone - vinanet.vn

Revvity Inc stock hits 52-week high at 130.07 USD By Investing.com - Investing.com Nigeria

Revvity Inc stock hits 52-week high at 130.07 USD - Investing.com

Revvity (NYSE: RVTY) director donates 285 shares in stock gift - Stock Titan

Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch

Revvity stock trades around $123 as investors weigh latest earnings and analyst targets - Ad-hoc-news.de

Why Revvity (RVTY) Stock Is Up Today - Quiver Quantitative

Revvity stock hits new 52-week high as gains extend - Ad-hoc-news.de

Revvity stock hits 52-week high at 122.26 USD - Investing.com

Revvity stock hits 52-week high at 122.26 USD By Investing.com - Investing.com India

Revvity Inc (RVTY) Shares Surge 5.0% -- What GF Score of 78 Tells Investors - GuruFocus

Revvity Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Revvity stock edges lower as SuperFlex launch and Q2 earnings shape valuation debate - Ad-hoc-news.de

Revvity Inc (RVTY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Revvity (NYSE: RVTY) executive gifts 27,785 shares to trust - Stock Titan

Revvity (NYSE:RVTY) Gains Attention After SuperFlex Launch - Kalkine Media

Revvity CEO Prahlad Singh Transfers Over 67,000 Shares to Family Trusts in Gift Transactions - Kalkine Media

Revvity (NYSE: RVTY) CEO shifts stock into family trusts at $0 - Stock Titan

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator with Modest Upside and Resilient Performance - DirectorsTalk Interviews

Revvity (NYSE:RVTY) Downgraded by Wall Street Zen to "Hold" - MarketBeat

T. Rowe Price (RVTY) reports 16.4% Revvity stake, 18.3M shares under control - Stock Titan

T. Rowe Price Associates (RVTY) discloses 5.0% beneficial stake in Revvity - Stock Titan

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs - Zacks Investment Research

Revvity (NYSE:RVTY) Hits New 12-Month HighWhat's Next? - MarketBeat

Revvyty Inc stock hits 52-week high at 118.34 USD By Investing.com - Investing.com South Africa

Simile a RVTY